ATI RN
ATI RN Pharmacology 2023 III Questions
Extract:
Question 1 of 5
A nurse is caring for a client who is receiving total parenteral nutrition (TPN). Which of the following actions should the nurse take to prevent adverse effects?
Correct Answer: C
Rationale: The correct answer is C: Change the IV tubing every 24 hours. This is crucial to prevent infection and maintain the integrity of the TPN solution. Regular tubing changes reduce the risk of bacterial growth and contamination, which can lead to serious complications like sepsis. Performing blood glucose monitoring hourly (
A) is important but not directly related to preventing adverse effects of TPN. Monitoring the client's weight weekly (
B) is not as immediate or critical as changing the IV tubing. Changing the IV dressing every 96 hours (
D) is too infrequent and increases the risk of infection.
Question 2 of 5
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
Correct Answer: D
Rationale: The correct answer is D: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs). Monitoring the WBC count is essential to evaluate the effectiveness of the treatment as an increase in WBC count indicates the medication is working to boost the immune system.
A: INR (International Normalized Ratio) is a measure of blood clotting, not relevant for evaluating filgrastim effectiveness.
B: BUN (Blood Urea Nitrogen) is a measure of kidney function, not related to filgrastim therapy.
C: Potassium level monitoring is important for other medications but not specifically for filgrastim.
In summary, monitoring the WBC count is crucial in assessing the response to filgrastim therapy, while the other laboratory values are not directly related to its effectiveness.
Question 3 of 5
A nurse is preparing to administer total parenteral nutrition to a client. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: The correct answer is B. Keeping the total parenteral nutrition solution refrigerated until 1 hour before infusion helps maintain its stability and prevent microbial growth. Changing the solution every 36 hours (
A) is unnecessary and could lead to wastage. Obtaining the client's weight three times a week (
C) is important for monitoring fluid balance but not directly related to administering TPN. Checking the client's WBC count daily (
D) is not necessary for administering TPN and may not be relevant to the client's condition.
Question 4 of 5
A nurse is assessing a client who is receiving a peripheral IV infusion and notes infiltration of fluid into the tissues surrounding the insertion site. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: The correct answer is B: Elevate the extremity. Elevating the extremity helps to reduce swelling and prevent further infiltration of fluid into the tissues. By raising the arm above the level of the heart, gravity helps to return the fluid back into the bloodstream. Applying pressure to the IV site (choice
A) may aggravate tissue damage. Flushing the IV catheter (choice
C) is not necessary in this situation and could exacerbate the issue. Slowing the infusion rate (choice
D) is not as effective as elevating the extremity in preventing further infiltration.
Question 5 of 5
A nurse is caring for a client who is taking warfarin and reports taking several new herbal supplements. The nurse should identify that which of the following supplements is contraindicated for concurrent use with warfarin?
Correct Answer: D
Rationale: The correct answer is D: Ginkgo biloba. Ginkgo biloba may increase the risk of bleeding when taken with warfarin due to its antiplatelet effects. Warfarin is an anticoagulant that works by inhibiting blood clotting factors. When combined with Ginkgo biloba, which also has anticoagulant properties, the risk of bleeding is significantly increased. Probiotics (
A), Coenzyme Q10 (
B), and Valerian (
C) do not have known interactions with warfarin that would increase the risk of bleeding. In summary, Ginkgo biloba is contraindicated due to potential additive anticoagulant effects, while the other options are safe to use concurrently with warfarin.